News Phase 3 Trial Evaluating Xeljanz’s Efficacy in Patients with Active Ankylosing Spondylitis Now Enrolling

News Ixekizumab Benefits Ankylosing Spondylitis Patients Who Failed to Respond to Standard Therapy, Phase 3 Study Shows

News #NORDSummit – Major Issues on Table for Rare Disease Patients in US as Midterm Elections Approach

News Anti-Rheumatic or Anti-Tumor Necrosis Therapy Does Not Contribute to Increased Infection Risk, Study Shows

News Filgotinib Safe, Effective in Treating Ankylosing Spondylitis, Phase 2 Trial Shows

News Cosentyx Safe, Effective Through 5 Years of Treatment, Novartis Announces

News Low Levels of Specific Immune Cell Linked to Ankylosing Spondylitis Manifestations, Mouse Study Suggests

A Wellness Journey - a Column by Lisa Marie Basile, Columns 3 Reasons to Be Thankful for Your AS Experience

News Advocacy Groups, Doctors Question Rising Prices of Rare Disease Treatments

News Gender-specific Predictors of AS Spinal Radiographic Progression Identified in 5-Year Study

A Wellness Journey - a Column by Lisa Marie Basile, Columns A Wellness Journey: 5 Excellent YouTube Videos About AS

News Humira Biosimilar, Hulio, Will Soon Be Available to AS, Other Patients in Europe

News Depression Prevalent in Axial Spondyloarthritis Patients, Linked to Disease Severity, Review Shows

A Wellness Journey - a Column by Lisa Marie Basile, Columns Newly Diagnosed? 4 Things You Should Know

News #NORDSummit – More Than 700 Expected to Attend Oct. 15-16 Rare Disease Summit in Washington

News AS Linked to Impaired Small Blood Vessels, But Manageable with Certain Inhibitors

News Cardiovascular Fitness of Patients Linked to Risk of Heart Disease in Study

News Filgotinib Seen to Reduce AS Disease Activity in Phase 2 Trial, Results Show

News Ankylosing Spondylitis Patients Have Different Biodiversity in Gut, Study Finds

News Biologics, Anti-TNF Therapy Protect AS Patients Against Heart Disease, Study Suggests

A Wellness Journey - a Column by Lisa Marie Basile, Columns A Wellness Journey: Self-care and Ankylosing Spondylitis

News Renflexis Now Reimbursed in British Columbia for Ankylosing Spondylitis, Other Indications

News Phase 2 Trial Opening in UK to Test Namilumab’s Effectiveness in Treating Ankylosing Spondylitis

News Pilot Study to Evaluate Cosentyx in Bone Health of AS Patients

News Humira Biosimilar Receives Positive Recommendation from European Medicines Agency Committee

News Blocking IL-23 Not Sufficient to Treat Ankylosing Spondylitis, Phase 2 Trial Finds

News Fatigue Linked to Work Disability in Ankylosing Spondylitis Patients, Study Shows

News Sandoz’s Biosimilar Zessly Approved in EU to Treat AS, Other Conditions

News Eli Lilly Announces Positive Results from Its 2nd Phase 3 Trial of Ixekizumab

News #EULAR2018 – Combo of TNF Inhibitors, NSAIDs Fight Long-Term Radiographic Progression of AS

News Cosentyx Added to Public Drug Programs Across Canada for Adults with Ankylosing Spondylitis

News #EULAR2018 – Latest Clinical Data on Cosentyx Reinforces Its Potential to Treat Ankylosing Spondylitis

News #EULAR2018 – Phase 2 Trial Results Show Bimekizumab Leads to Improvements in AS Activity

News Women Have Reduced Response to Ankylosing Spondylitis Treatments, Study Finds

News Study Calls into Question Suspected Genetic Risk Factor for Ankylosing Spondylitis

News Social Media Allows Glimpse into AS Patients’ Thoughts on Biologics

Just Published, News Hypertension, Depression More Common in Patients Than Others of Same Age and Sex, Study Reports

A Wellness Journey - a Column by Lisa Marie Basile, News Lupin Seeks EU Marketing Approval for YLB113, Etanercept Biosimilar, for Ankylosing Spondylitis

News US ‘Right to Try’ Law Meets with Mix of Praise and Criticism, Including Among Those with Rare Diseases

News Humira of Benefit Over Long Term to Nonradiographic Axial Spondyloarthritis Patients, Study Reports

News #ERDC2018 – When Treating Rare Disease Patients, Don’t Overlook Quality of Life, Panel Urges

News Cimzia Shows Promise in Managing nr-axSpA Disease Activity, Symptoms in Phase 3 Trial

News Mylan and Fujifilm Kyowa Kirin to Commercialize Humira Biosimilar in EU

News ‘Rare Impact Awards’ Dinner Marks Orphan Drug Act and NORD at 35

News Secukinumab Treatment Linked to Inflammatory Bowel Disease Symptoms in Some Cases

News #ECRD2018 – EU Must Do More for Rare Disease Patients, Eurordis Leaders Say

News Patient Support Services Linked with Better Health Outcomes in Ankylosing Spondylitis Patients

News 4 More Canadian Provinces Add Erelzi to Public Drug Plans for Inflammatory Diseases

News Ankylosing Spondylitis Patients More Likely to Develop COPD, Researchers Find

News Pregnancy Can Affect Axial Spondyloarthritis Activity, Prospective Study Suggests

News #ECRD2018 – Patient Access and Collaboration Focus of Eurordis Meeting May 10-12

News Increase in Early Spondyloarthritis Activity Linked to Decline in Physical Quality of Life, Study Shows

News Spondylitis Association of America Launches National Campaign for Awareness Month

News Levels of Fat in Blood May Detect Heart Disease in AS Patients, Study Suggests

News NIH Agency Pioneers Collaborative Research into Rare Diseases

News Only 30% of Those with Inflammatory Back Pain Develop Spondyloarthritis, Study Finds

News FDA-Approved Label Change for Cimzia Important for Childbearing Women with Inflammatory Diseases

News 2 New Biomarkers May Help Detect Axial SpA Risk in IBD Patients, Study Finds

News Chinese Identify Proteins That Could Become Ankylosing Spondylitis Therapy Targets

News Anterior Uveitis Increases Risk of Developing Ankylosing Spondylitis, Study Finds

News Demographics and Certain Symptoms Linked to Increased Disability in AS Patients, Korean Study Finds

News Russia Approves Its Local Company BIOCAD’s Infliximab Biosimilar for Ankylosing Spondylitis

News Genome Sequencing and Its Clinical Potential Focus of NYC Rare Disease Day Event

News ‘A Disease May Be Rare, Hope Should Never Be,’ Says Boy with SMARD at Connecticut Rare Disease Day Event

News Cimzia Prevented Disease Progression, Inflammation in Axial SpA, Phase 3 Trial Shows

News Rare Disease Groups Welcome FDA’s Embrace of ‘Real World’ Data in Clinical Trials

News AS Patients Can Benefit from Switching Anti-TNF Therapies When One Stops Working, Study Suggests

News US Lawmakers Urge Bipartisan Support for Rare Disease Research, Patients’ Needs

News Cosentyx Leads to Long-Term Improvement in AS Patients, Phase 3 Trial Shows

News Ixekizumab Shows Promise in Phase 3 Trial of Radiographic Axial Spondyloarthritis

News Retrophin, Horizon Donate $3M Each to Rare Disease Institute at Children’s National

News Active Inflammation in Bone is Major Risk Factor for AS Patients

News BioNews to Cover 3 Rare Disease Day Events, Including NIH Conference

News Patient Advocacy Groups Worldwide Plan Events to Mark Rare Disease Day, Feb. 28

News NICE Recommends Simponi for Severe Non-Radiographical AS in England, Wales

News Patients Who Don’t Respond Initially to TNFi inhibitors Share Similarities, Study Finds

News Biologic DMARDs Do Not Prevent Spinal Fractures in AS Patients, Swedish Study Shows

News Rare Disease Groups, Patients Differ on ‘Right to Try’ Bill Before US Congress

News Researchers Identify Promising Biomarkers for AS Diagnosis, Prognosis

News Top-line Data Awaited in Phase 2b Trial of Alternative to Naproxen as Painkiller

News NORD Fundraiser Sets 7,000-Mile ‘Bike, Run or Walk’ Goal for 7,000 Rare Diseases

News Femoral Neck the Best Site to Measure Bone Loss in AS Patients, Swedish Study Finds

News Early Disease Onset, Long Duration Increase Comorbidity Risk in Ankylosing Spondylitis, Study Suggests

News Simponi Aria a Safe, Effective Therapy for AS Patients, Phase 3 Trial Shows

News Endothelium Function in AS Improved with Methotrexate Alone or Combined with Anti-TNF Agents, Study Finds

News EU Approves Cimzia for Pregnant and Breastfeeding Women with a Rheumatic Disease

Columns, Persevering with AS - a Column by Christina Lowe A Solid Foundation and Community Will Keep You Standing

News Novartis Initiates Phase 3 Trial in AS Comparing Cosentyx to Adalimumab Biosimilar

Columns, Persevering with AS - a Column by Christina Lowe The New Year and the Journey Ahead

News Pain in AS May Be Caused by Sources Other Than Spine Inflammation, Opioid Study Suggests

News Low-dose CT Can Improve Assessment of Ankylosing Spondylitis Progression, Study Suggests

News UCB’s Bimekizumab Shows Promising Results in AS Clinical Trial

News FDA Approves Ixifi, a Remicade Biosimilar, for Ankylosing Spondylitis, Other Indications

News Axial Spondyloarthritis Patients Who Stop Smoking Lower Disease Activity, Feel Better

News Study Launched to Assess Impact of Higher Dose of Cosentyx in Patients with AS

News Nearly a Fifth of IBD Patients Have a Joint Condition, Veterans Study in Texas Indicates

News More Research Needed to Understand Why AS Patients Quit Taking TNF Blockers, Study Concludes

News Two Canadian Provinces Add Biosimilar Erelzi to Treatment Plan for Inflammatory Diseases

News New Autoinjector for Prefilled, Single-Dose Enbrel Now Available in the U.S.

News Rare Disease Patient Groups Unite to Preserve Orphan Drug Tax Credit in US